Acanthosis Nigricans and Its Response to Metformin

Dinesh Giri; Hussain Alsaffar; Renuka Ramakrishnan

doi:10.1111/pde.13206

Acanthosis Nigricans and Its Response to Metformin

Dinesh Giri, Hussain Alsaffar, Renuka Ramakrishnan^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Acanthosis nigricans (AN) is the most common cutaneous manifestation of insulin resistance (IR) and is commonly seen in non-Caucasian populations. Variable benefits of metformin in the treatment of AN have been reported in the literature. We report an adolescent Caucasian boy with IR and extensive AN who showed complete resolution of AN after 2 years of metformin, despite persistence of IR.

Original language	English
Pages (from-to)	e281-e282
Journal	Pediatric Dermatology
Volume	34
Issue number	5
DOIs	https://doi.org/10.1111/pde.13206
Publication status	Published - Sept 1 2017
Externally published	Yes

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Dermatology

Access to Document

10.1111/pde.13206

Cite this

@article{613ce5bd3c294dff9e7ae2956d851961,

title = "Acanthosis Nigricans and Its Response to Metformin",

abstract = "Acanthosis nigricans (AN) is the most common cutaneous manifestation of insulin resistance (IR) and is commonly seen in non-Caucasian populations. Variable benefits of metformin in the treatment of AN have been reported in the literature. We report an adolescent Caucasian boy with IR and extensive AN who showed complete resolution of AN after 2 years of metformin, despite persistence of IR.",

author = "Dinesh Giri and Hussain Alsaffar and Renuka Ramakrishnan",

note = "Publisher Copyright: {\textcopyright} 2017 Wiley Periodicals, Inc.",

year = "2017",

month = sep,

day = "1",

doi = "10.1111/pde.13206",

language = "English",

volume = "34",

pages = "e281--e282",

journal = "Pediatric Dermatology",

issn = "0736-8046",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Acanthosis Nigricans and Its Response to Metformin

AU - Giri, Dinesh

AU - Alsaffar, Hussain

AU - Ramakrishnan, Renuka

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Acanthosis nigricans (AN) is the most common cutaneous manifestation of insulin resistance (IR) and is commonly seen in non-Caucasian populations. Variable benefits of metformin in the treatment of AN have been reported in the literature. We report an adolescent Caucasian boy with IR and extensive AN who showed complete resolution of AN after 2 years of metformin, despite persistence of IR.

AB - Acanthosis nigricans (AN) is the most common cutaneous manifestation of insulin resistance (IR) and is commonly seen in non-Caucasian populations. Variable benefits of metformin in the treatment of AN have been reported in the literature. We report an adolescent Caucasian boy with IR and extensive AN who showed complete resolution of AN after 2 years of metformin, despite persistence of IR.

UR - http://www.scopus.com/inward/record.url?scp=85026475514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026475514&partnerID=8YFLogxK

U2 - 10.1111/pde.13206

DO - 10.1111/pde.13206

M3 - Article

C2 - 28758315

AN - SCOPUS:85026475514

SN - 0736-8046

VL - 34

SP - e281-e282

JO - Pediatric Dermatology

JF - Pediatric Dermatology

IS - 5

ER -

Acanthosis Nigricans and Its Response to Metformin

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this